Professional Background &
Medical Expertise

Dr. Dorothea Schlesinger

Specialist title
  • Specialist in internal medicine, endocrinology and diabetology
  • Osteologist DVO
  • Health economics
Professional experience/medical activity
  • 10/2006- 09/2007
    Practical year at the University of Sydney, University of Queensland (Australia) and Weimar
  • 2/2008-1/2011
    Doctor at the University of Queensland, Australia, Mater Hospital, Caboolture Hospital. Acquired sound basic knowledge of internal medicine (cardiological, oncological, nephrology, pulmonology wards)
  • 04/2011-01/2012
    Doctor at the Department of Internal Medicine with a focus on endocrinology and metabolic diseases at Jena University Hospital (Prof. Dr. Müller)
  • 02/2012-10/2013
    Physician in the Department of Internal Medicine with a focus on endocrinology and metabolic diseases at the University Hospital Erlangen (Mentor: Prof. Dr. Christof Schöfl)
  • 10/2013-08/2015
    Research project/doctor at the University of Sydney, investigating the mechanisms of parathyroid hormone secretion
  • 02/2014
    Fellow of the Royal Australasian College of Physicians (FRACP) examination (Australian specialist examination)
  • 09/2015–03/2019
    Employed doctor in the endocrinology group practice Happ-Santen-Engelbach in Frankfurt am Main
  • Since 04/2019
    Employed doctor with PD Dr. Rau, Nuclear Medicine and Endocrinology Aschaffenburg
  • 10/2020–06/2021
    Intensive Study Program Health Economics (45th year) at the EBS Executive School
University education
  • 10/2000- 10/2007
    Medical studies at the Friedrich Schiller University of Jena
  • 10/2003-11/2011
    Doctorate at the Institute of Pathology, Immunopathology Group of FSU Jena with Professor Dr. Bräuer.
    Dissertation topic: "Induction and functional characterization of tolerogenic dendritic cells."
    Doctorate with "magna cum laude"
  • Scholarship holder of the IZKF (Interdisciplinary Center for Clinical Research)
    Research project topic: "Suppression der etablierten Immunantworten mit tolerogenen dendritischen Zellen."
Continuing education
  • Harvard Medical School
    Testosterone Therapy and Sexual Dysfunction January 2026
  • Harvard Medical School
    Clinical Endocrinology Update March 2026 (view certificate)
  • Mayo Clinic
    Endocrine Update January 2026 (view certificate )
  • Mayo Clinic
    22nd Annual Women's Health Update March 2026 (view certificate)
  • Oxford
    Clinical Training Course 2026 (view certificate)
  • ESA Seminar
    The Annual Endocrine Society of Australia Seminar 2026 (view certificate)
  • 28th Madrid World Congress ISMST
    Medical Shockwave Therapy June 2026 (view certificate)
Scientific engagement
  • Poster presentation
    "Suppression of established immune responses by tolerogenic dendritic cells" at the International Congress on Dendritic Cells in Bruges, Belgium (2004)
  • Scholarship of the Boehringer Ingelheim Fund for the research project with Prof. R. Thomas
    "Molecular Mechanisms of the Regulation of Toll-like Receptor Expression," Princess Alexandra Hospital Diamantina Institute Brisbane, Australia
  • Publication in journal Clinical Endocrinology Metabolism.
    "A homozygous CaSR mutation causing an FHH phenotype completely masked by vitamin D deficiency presenting as rickets." JCEM, June 2014
  • Poster presentation
    "An Intrinsic Mechanism of Parathyroid Hormone Secretion Based on Prostanoid EP4 and IP1 Receptors," Endocrine Society Meeting in San Diego, 2015
Memberships
  • Endocrine Society